Cheri Ackerman

Company: Concerto Biosciences

Job title: Director

Seminars:

Modulating Microbial Behaviors to Treat Skin Disease: ENS-002 in Atopic Dermatitis & 33 Million Data Points for Targeted Microbial Interventions 10:35 am

Discover how Concerto’s kChip platform identified ENS‑002 by screening over 5 million microbial combinations Highlight the Phase I trial testing ENS‑002’s safety and impact on Staphylococcus aureus in AD patients Explore how microbe-based therapies like ENS‑002 can provide long-term relief without the risks of immunosuppression Preview the Skin Universe Project’s role in enabling future microbial…Read more

day: Day One AM